Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Confirmatory, Randomised 1:1 Double-blind, Placebo-controlled Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.

NCT06023706 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT06023706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06023706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Confirmatory, Randomised 1:1 Double-blind, Placebo-controlled Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.
Lead sponsor
Nantes University Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
November 8, 2023
Completion date
October 8, 2027
Enrollment
188 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

coccygodynia, coccyx disorder, neuropathic pain